Febuxostat National Contract

Agency: DEPT OF DEFENSE
State: Federal
Type of Government: Federal
NAICS Category:
  • 325412 - Pharmaceutical Preparation Manufacturing
Set Aside: Original Set Aside:
Posted Date: Dec 29, 2020
Due Date: Dec 28, 2025
Solicitation No: SPE2D2-21-R-0101
Original Source: Please Login to View Page
Contact information: Please Login to View Page
Bid Documents: Please Login to View Page

Description

Febuxostat National Contract
Active
Contract Opportunity
Notice ID
SPE2D2-21-R-0101
Related Notice
Department/Ind. Agency
DEPT OF DEFENSE
Sub-tier
DEFENSE LOGISTICS AGENCY (DLA)
Major Command
TROOP SUPPORT MEDICAL
Office
DLA TROOP SUPPORT
General Information
  • Contract Opportunity Type: Presolicitation (Original)
  • All Dates/Times are: (UTC-05:00) EASTERN STANDARD TIME, NEW YORK, USA
  • Original Published Date: Dec 29, 2020 08:43 am EST
  • Original Response Date: Dec 28, 2025 03:00 pm EST
  • Inactive Policy: 15 days after response date
  • Original Inactive Date: Jan 12, 2026
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: 6505 - DRUGS AND BIOLOGICALS
  • NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing
  • Place of Performance:
Description

The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Febuxostat. Procurement details follow.

Febuxostat Tablets 40 MG and 80 MG in 30 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.

A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Beta Sam.Gov at https://beta.sam.gov/. Interested parties should contact Denise Taubman (denise.taubman@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is February 2021. DLA reserves the right to issue the solicitation before or after the projected solicitation date.

The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Febuxostat. Procurement details follow.

Febuxostat Tablets 40 MG and 80 MG in 30 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.

A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Beta Sam.Gov at https://beta.sam.gov/. Interested parties should contact Denise Taubman (denise.taubman@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is February 2021. DLA reserves the right to issue the solicitation before or after the projected solicitation date.

Attachments/Links
Contact Information
Contracting Office Address
  • MEDICAL SUPPLY CHAIN FSGB 700 ROBBINS AVENUE
  • PHILADELPHIA , PA 19111
  • USA
Primary Point of Contact
Secondary Point of Contact
History
  • Dec 29, 2020 08:43 am ESTPresolicitation (Original)
Get Government Bids Like This by Email Receive daily bid alerts that match your keywords, business categories, and target regions.
* Disclaimer: This website provides information about bids, requests for proposals (RFPs), or requests for qualifications (RFQs) for convenience only and does not serve as an official public notice. Individuals who wish to respond to or inquire about bids, RFPs, or RFQs should contact the relevant government department directly.